Related Experiment Video
Updated: Aug 14, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
Published on: September 20, 2010
Primary brain tumors in the acquired immunodeficiency syndrome
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Insights
Primary central nervous system lymphoma is a common brain tumor in AIDS patients, often presenting as enhancing masses. While cranial irradiation offers temporary tumor regression, combining chemotherapy with radiotherapy may improve survival for some.
Area of Science:
- Neuro-oncology
- Infectious Diseases
- Immunology
Background:
- Primary central nervous system lymphoma (PCNSL) is the most frequent brain tumor in individuals with acquired immunodeficiency syndrome (AIDS), affecting approximately 10% of this population.
- Clinical presentation often includes altered mental status and lateralizing neurological signs.
- Radiological imaging (CT/MRI) typically reveals contrast-enhancing masses that are difficult to distinguish from other central nervous system (CNS) conditions like toxoplasmosis.
Purpose of the Study:
- To summarize the diagnostic challenges and therapeutic outcomes for primary central nervous system lymphoma in patients with acquired immunodeficiency syndrome.
Main Methods:
- Review of clinical presentations, diagnostic modalities, and treatment strategies for PCNSL in AIDS patients.
- Discussion of diagnostic methods including brain biopsy and Epstein-Barr viral DNA detection in cerebrospinal fluid.
- Analysis of treatment outcomes for cranial irradiation and combined chemotherapy-radiotherapy approaches.
Main Results:
- Definitive diagnosis of PCNSL in AIDS patients often requires brain biopsy or detection of Epstein-Barr viral DNA in cerebrospinal fluid.
- Cranial irradiation is a standard therapy, inducing tumor regression in most cases but resulting in short median survival (a few months).
- Combining chemotherapy with radiotherapy shows promise, potentially extending survival to 1-2 years in a subset of patients.
Conclusions:
- PCNSL in AIDS patients presents diagnostic and therapeutic challenges due to its similarity to other CNS infections.
- While cranial irradiation provides symptomatic relief, novel therapeutic combinations are needed to improve long-term survival.
- Chemotherapy combined with radiotherapy represents a potential advancement for select patients, offering improved survival outcomes.
Abstract:
Primary central nervous system lymphoma occurs in about 10% of patients with the acquired immunodeficiency syndrome, and is the most common brain tumor in this population. Patients present with an altered mental status and lateralizing signs. Computed tomography or magnetic resonance scan usually demonstrates single or multiple contrast-enhancing masses which are indistinguishable from toxoplasmosis or other central nervous system processes. Brain biopsy or possibly the demonstration of Epstein-Barr viral DNA in the cerebrospinal fluid are the only definitive means of diagnosis. Cranial irradiation has been the cornerstone of therapy, producing regression of tumor in most patients; however, median survival is only a few months. Recent experience of combining chemotherapy with radiotherapy suggests that a subgroup of patients can benefit from this approach, with survival reaching 1-2 years.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis
Encephalitis l: Introduction
Brain Abscess l: Introduction

